Axon Plans $1B Notes, Credit Line Expansion
Axon Plans $1B Notes, Credit Line Expansion
Anonymous
Key Points
1
The new zero-coupon offering marks a major change from Axon’s recent debt financing: in March 2025, the company issued $1 billion of 6.125% senior notes due 2030 and $750 million of 6.250% senior notes due 2033.
2
The amended revolving facility will bear interest at SOFR plus 1.25% to 1.75% and will remain subject to leverage and interest-coverage covenants; its maturity is expected to extend to as much as five years after the amendment closes.
3
Axon may begin redeeming all or part of the notes on or after September 20, 2029 if its stock trades at least 130% of the conversion price for 20 trading days within a consecutive 30-trading-day period. It may also redeem the notes if less than 10% of the original principal remains outstanding.
4
The offering is being led by Goldman Sachs, Morgan Stanley, J.P. Morgan, RBC Capital Markets and Citigroup as joint lead book-running managers, and the underwriters’ overallotment option is exercisable during an 11-day period beginning when the notes are issued.
5
Axon previously issued $690 million of 0.50% convertible notes due 2027 in a 2022 Rule 144A transaction. In February 2026, it redeemed $840,000 of that issue and settled conversions covering $80.27 million of principal with approximately $80.3 million in cash and 211,870 shares.
Axon Enterprise plans to raise $1 billion through zero-coupon convertible senior notes due September 2031, marking a sharp shift toward cheaper debt. Yahoo Finance reported that shares fell 8.7% after the announcement, as investors worried about potential stock dilution. The company also expanded its credit line from $300 million to $500 million, pending completion of the notes offering.
The zero-coupon structure contrasts sharply with Axon's recent financing. In March 2025, the company issued $1 billion in 6.125% senior notes and $750 million in 6.250% senior notes. The new deal lets Axon access capital without paying regular interest, freeing cash for growth and acquisitions.
From High-Coupon Debt to Zero-Interest Bonds
Axon's latest move reverses course from expensive borrowing earlier this year. The company issued $1.75 billion in fixed-rate senior notes at 6% to 6.25% interest in March 2025. Now it's tapping zero-coupon convertibles instead. This switch cuts future cash interest payments to zero while pushing repayment into 2031.
The convertible structure lets Axon convert debt into stock rather than pay cash back. Investors can convert each $1,000 note into 1.5336 shares at $652.06 per share. That price sits 47.5% above where the stock closed on the announcement day, giving bondholders upside potential if Axon's stock rises.
Stock Dilution Fears Send Shares Down 10%
Axon's stock dropped sharply on the news. Yahoo Finance said shares fell 8.7% in the morning session after the company announced the $1 billion offering. Heavy selling pushed the stock down another point or two by day's end. Investors fear that converting debt into shares will dilute existing shareholders' ownership stakes.
The company is using capped call transactions to cushion some dilution. Axon will spend $99.9 million on these protective contracts. The calls let Axon cap the total shares issued if the stock surges past $1,049.94. Without the capped calls, a sharp stock rally could force Axon to issue far more shares.
Credit Line Boost Gives Axon Room to Spend
Beyond the convertible notes, Axon doubled its credit flexibility. The company amended its revolving credit agreement to raise the borrowing limit from $300 million to $500 million. An additional $150 million option is available if needed. The facility carries interest at SOFR plus 1.25% to 1.75% and matures up to five years after the amendment closes.
This expanded credit line gives Axon dry powder for acquisitions and product launches. The company retains roughly $886 million in net proceeds from the notes after capped call costs. Combined with the new $200 million in base credit availability, Axon can pursue growth without running short on cash.
Redemption Window Opens in Late 2029
Axon can begin redeeming the notes starting September 20, 2029 if certain conditions are met. The stock must trade above 130% of the conversion price—around $847.68—for 20 trading days within any 30-day window. If that happens, Axon can call in all or part of the notes and refinance at better terms or pay them off with cash.
The company can also force redemption if less than 10% of the original $1 billion in notes remains outstanding after conversions. This flexibility lets Axon manage its debt stack as the business grows and its stock price moves higher.
Sentiment
Mostly PositiveNEGATIVENEUTRALPOSITIVE
Publishers
32
Articles
78
Reach
110
A
AnonymousAuthor
